Stress hyperglycaemia in critically ill patients: Potential role of incretin hormones; a preliminary study Hiperglucemia de estrés en el paciente crítico: papel potencial de las incretinas; estudio preliminar

Stress hyperglycaemia in critically ill patients: Potential role of incretin hormones; a preliminary study Hiperglucemia de estrés en el paciente crítico: papel potencial de las incretinas; estudio preliminar

Background: Stress hyperglycaemia is common in the intensive care unit (ICU) setting and has been related to a worst outcome. Objective: The objective was to characterize the association of glucoregulatory hormones, mainly incretins, with the levels of glycaemia, and its relationship with outcome in...

Full description

Bibliographic Details
Main Authors:	J. A. Llompart-Pou, A. G. Fernández-de-Castillo, B. Burguera, J. Pérez-Bárcena, P. Marsé, M. Rodríguez-Yago, A. Barceló, J. M.ª Raurich
Format:	Article
Language:	English
Published:	Arán Ediciones, S. L. 2012-02-01
Series:	Nutrición Hospitalaria
Subjects:	Hiperglucemia de estrés Incretinas Polipéptido insulinotropo dependiente de glucosa Péptido-1 de tipo glucagón Pacientes críticos Stress hyperglycaemia Incretins Glucosedependent insulinotropic polypeptide Glucagon-like peptide-1 Critically ill patients
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000100015

Similar Items

Regulación de la dinámica y metabolismo mitocondrial por incretina GLP-1 en células de la línea A7r5
by: Torres Rivera, Gloria Andrea
Published: (2014)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
by: Soyeon Yoo, et al.
Published: (2021-06-01)

Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
by: E A Shestakova, et al.
Published: (2014-10-01)

Las incretinas: nueva alternativa terapéutica para el control glucometabólico de la diabetes mellitus de tipo 2 Incretins: a new therapeutic alternative for the glycometabolic control of the type 2 diabetes mellitus
by: Yaily Lazo Roblejo, et al.
Published: (2012-03-01)

Insulin Secretion and Incretin Hormone Concentration in Women with Previous Gestational Diabetes Mellitus
by: Sung Hoon Yu, et al.
Published: (2011-02-01)

Effects of passage through the digestive tract on incretin secretion: Before and after birth
by: Seiichi Tomotaki, et al.
Published: (2021-06-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Efectos de la incretina glp-1 sobre el acoplamiento retículo endoplásmico-mitocondria en células de músculo liso vascular : rol de pka y mitofusina-2
by: Morales Campos, Pablo Esteban
Published: (2013)

Effects of passage through the digestive tract on incretin secretion: Before and after birth
by: Tomotaki, Seiichi
Published: (2021)

Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
by: I I Dedov, et al.
Published: (2016-10-01)

Serum Levels of Incretin Hormones – GLP-1 and GIP in Patients with Type 1 Diabetes Mellitus
by: Stanchev Pavel E., et al.
Published: (2019-03-01)

Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
by: Danielle M. Fitzgerald, et al.
Published: (2019-01-01)

Desarrollo y caracterización de un conjugado del péptido análogo a glucagón (GLP-1) a nanopartículas de oro, como nueva forma de entrega de biomoléculas con potencial aplicación en diabetes
by: Pérez Ortiz, María Magdalena
Published: (2014)

Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses
by: Line Engelbrechtsen, et al.
Published: (2018-03-01)

Inhibidores de la dipeptidil peptidasa 4 y una nueva estrategia farmacológica en la diabetes mellitus tipo 2
by: Ernesto Alfonso Figueredo, et al.

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-04-01)

Glycemic and Metabolic Effects of Two Long Bouts of Moderate-Intensity Exercise in Men with Normal Glucose Tolerance or Type 2 Diabetes
by: Saeed Reza Eshghi, et al.
Published: (2017-07-01)

Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
by: M S Arutyunova, et al.
Published: (2015-10-01)

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
by: Miaad Bader, et al.
Published: (2020-01-01)

Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes
by: Tsuyoshi Yanagimachi, et al.
Published: (2020-04-01)

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
by: Nadya M. Morrow, et al.
Published: (2021-09-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)

Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019-04-01)

COMPARISON OF THE LEVELS OF C-REACTIVE PROTEIN, GLP-1 AND GLP-2 AMONG INDIVIDUALS WITH DIABETES, MORBID OBESITY AND HEALTHY CONTROLS: AN EXPLORATORY STUDY
by: Everton CAZZO, et al.

Identificación de células enteroendocrinas productoras del peptido similar al glucagón tipo-1(glp-1) en intestinos de alpacas
by: Hidalgo Pérez, César Armando
Published: (2015)

Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
by: Jared Rosenberg, et al.
Published: (2021-09-01)

Determinación del efecto del gel de Aloe vera, sobre la glicemia en caninos sanos
by: María Mercedes Tamayo, et al.
Published: (2011-02-01)

A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers
by: Kishimoto Miyako, et al.
Published: (2011-12-01)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
by: David S. Mathiesen, et al.
Published: (2019-08-01)

Efecto incretina en el tratamiento de la diabetes mellitus tipo 2
by: Manuel de Jesús Díaz Pérez, et al.
Published: (2015-02-01)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
by: Jens Juul Holst
Published: (2019-04-01)

The Impact of a Large Bolus Dose of <span style="font-variant: small-caps">l</span>-leucine and <span style="font-variant: small-caps">l</span>-isoleucine on Enteroendocrine and Pancreatic Hormones, and Glycemia in Healthy, Inactive Adults
by: Daniel E. Newmire, et al.
Published: (2019-11-01)

DOES PALM MID FRACTION AFFECT ADULT SATIETY?
by: Lee, V.K.M, et al.
Published: (2021)

Modelling the effects of glucagon during glucose tolerance testing
by: Ross A. Kelly, et al.
Published: (2019-12-01)

Understanding the Cardiovascular Effects of Incretin
by: Ji Sung Yoon, et al.
Published: (2011-10-01)

A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide-expressing cells in the hypothalamus
by: Adriaenssens, A., et al.
Published: (2022)

Stathmin-2 Mediates Glucagon Secretion From Pancreatic α-Cells
by: Farzad Asadi, et al.
Published: (2020-02-01)

Potential for Gut Peptide-Based Therapy in Postprandial Hypotension
by: Malcolm J. Borg, et al.
Published: (2021-08-01)

Variación de los Niveles de glucosa sanguínea en pacientes caninos sometidos a orquiectomía
by: Villar Amasifuen, Emily Scarlett
Published: (2016)

A modulação crônica do receptor de GLP-1 altera aos níveis pressóricos, a estrutura e a função renal de ratos espontaneamente hipertensos
by: Gabriela Cozin Aragão
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ndopforgsvqje4thn8fkm9hp8e